Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1530739/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841560985188433920 |
---|---|
author | Katarzyna Bogunia-Kubik Philippe Saas Philippe Saas Eric Toussirot |
author_facet | Katarzyna Bogunia-Kubik Philippe Saas Philippe Saas Eric Toussirot |
author_sort | Katarzyna Bogunia-Kubik |
collection | DOAJ |
format | Article |
id | doaj-art-ab2c1a5a37574d1f87aed6fc4c7e98b2 |
institution | Kabale University |
issn | 1664-3224 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj-art-ab2c1a5a37574d1f87aed6fc4c7e98b22025-01-03T08:55:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15307391530739Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume IIKatarzyna Bogunia-Kubik0Philippe Saas1Philippe Saas2Eric Toussirot3Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, PolandInstitute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, FranceEtablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, FranceUniversité de Franche Comté, INSERM Centre Investigation Clinique CIC-1431, CHU de Besançon, Besançon, Francehttps://www.frontiersin.org/articles/10.3389/fimmu.2024.1530739/fullTNF inhibitorsbiomarkerscell-based therapyinflammatory rheumatic diseasespsoriatic arthritisrheumatoid arthritis |
spellingShingle | Katarzyna Bogunia-Kubik Philippe Saas Philippe Saas Eric Toussirot Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II Frontiers in Immunology TNF inhibitors biomarkers cell-based therapy inflammatory rheumatic diseases psoriatic arthritis rheumatoid arthritis |
title | Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II |
title_full | Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II |
title_fullStr | Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II |
title_full_unstemmed | Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II |
title_short | Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II |
title_sort | editorial community series in recent advances in potential biomarkers for rheumatic diseases and in cell based therapies in the management of inflammatory rheumatic diseases volume ii |
topic | TNF inhibitors biomarkers cell-based therapy inflammatory rheumatic diseases psoriatic arthritis rheumatoid arthritis |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1530739/full |
work_keys_str_mv | AT katarzynaboguniakubik editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii AT philippesaas editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii AT philippesaas editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii AT erictoussirot editorialcommunityseriesinrecentadvancesinpotentialbiomarkersforrheumaticdiseasesandincellbasedtherapiesinthemanagementofinflammatoryrheumaticdiseasesvolumeii |